Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2019 August;85(8) > Minerva Anestesiologica 2019 August;85(8):822-9

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

ORIGINAL ARTICLE   Freefree

Minerva Anestesiologica 2019 August;85(8):822-9

DOI: 10.23736/S0375-9393.19.13388-3

Copyright © 2019 EDIZIONI MINERVA MEDICA

language: English

Comparison of the incidence of perioperative cardiovascular risk events among patients with and without a history of neoadjuvant chemotherapy

Wen ZHANG 1, Kangjie XIE 1, Shuang FU 1, Huifang JIANG 1, Man FANG 1, Yanhong LIAN 1, Wujun GENG 2, Jun FANG 1

1 Department of Anesthesiology, Zhejiang Cancer Hospital, Hangzhou, China; 2 Department of Anesthesiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China



BACKGROUND: Chemotherapy predisposes individuals to increased risk for future cardiac events.
METHODS: In order to verify the hypothesis that neoadjuvant chemotherapy may be a risk factor for perioperative cardiovascular events, 122 patients who underwent radical mastectomy with general anesthesia were separated into two groups, the N group (neoadjuvant chemotherapy group) and the C group (control group), according to neoadjuvant chemotherapy history. Cardiovascular events were recorded in 24 hours after surgery.
RESULTS: There were no differences in demographic characteristics such as age, body mass index and electrocardiogram between the two groups. The N group had higher atherosclerosis index, lower preoperative echocardiographic ejection fraction and hemoglobin values than the C group. The N group had significantly higher incidence of cardiovascular risk events (16.1%) than the C group (5%) (P<0.05). After binary logistic regression, neoadjuvant chemotherapy was identified as a risk factor of cardiovascular risk events.
CONCLUSIONS: Patients who underwent neoadjuvant chemotherapy prior to radical mastectomy were more prone to cardiovascular risk events than those without chemotherapy history.


KEY WORDS: Breast neoplasms; Cardiovascular abnormalities; Drug therapy; Anesthesia, general

top of page